Related Experiment Video
Updated: Jan 23, 2026

Modeling Brain Metastasis Via Tail-Vein Injection of Inflammatory Breast Cancer Cells
Published on: February 4, 2021
Recent trends in the utilization of molecular breast imaging in the United States
Ria Dave1, Lin Gu2, Heather V Garrett2
1NIH TL1 Predoctoral Program, Washington University School of Medicine, 510 S. Kingshighway, St. Louis, MO, 63110, United States of America; University of Missouri-Kansas City School of Medicine, 2411 Holmes St, Kansas City, MO, 64108, United States of America.
Objective:
The objective of this study was to assess trends in Molecular Breast Imaging (MBI) utilization among privately insured women in the United States (U.S.) from 2017 to 2022.
Methods:
The utilization of MBI among women aged 25-64 years from January 1, 2017, to December 31, 2022, was obtained using the Merative MarketScan Commercial Database. MBI utilization was captured from the outpatient services file using Current Procedural Terminology (CPT) or Healthcare Common Procedure Coding System (HCPCS) codes for MBI.
Results:
During the 6-year retrospective claims analysis, 3024 study-eligible women underwent 3648 MBI exams. The overall trend in MBI utilization was relatively stable from 2017 to 2021, with a 33% reduction in utilization in 2022. The lowest utilization rate was in 2022 at 5.6 per 1000 person-years of observation. Of the women who underwent MBI with sufficient follow-up, 83% underwent only one examination during the study period.
Conclusion:
MBI is consistently underutilized during the study period despite its accuracy, affordability, and safety for diagnosing breast cancer.
Related Concept Videos
Current Trends in Nursing I
Current Trends in Nursing II
Issues And Trends In Healthcare Delivery System
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Molecular Models
Molecular Orbital Theory II
Measurement: Standard Units

